Loading…

Changes in the characteristics of community-onset fluoroquinolone-resistant Escherichia coli isolates causing community-acquired acute pyelonephritis in South Korea

This study aimed to examine the changes in the characteristics of community-onset fluoroquinolone-resistant (FQ-R) Escherichia coli isolates causing community-acquired acute pyelonephritis (APN) in South Korea. Blood or urine samples were prospectively collected from patients aged ≥15 years with com...

Full description

Saved in:
Bibliographic Details
Published in:Journal of microbiology, immunology and infection immunology and infection, 2022-08, Vol.55 (4), p.678-685
Main Authors: Kim, Bongyoung, Kim, Jeoungyeon, Jo, Hyun-uk, Kwon, Ki Tae, Ryu, Seong-yeol, Wie, Seong-Heon, Kim, Jieun, Park, Se Yoon, Hong, Kyung-Wook, Kim, Hye In, Kim, Hyun ah, Kim, Mi-Hee, Bae, Mi Hyun, Sohn, Yong-Hak, Lee, Yangsoon, Pai, Hyunjoo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aimed to examine the changes in the characteristics of community-onset fluoroquinolone-resistant (FQ-R) Escherichia coli isolates causing community-acquired acute pyelonephritis (APN) in South Korea. Blood or urine samples were prospectively collected from patients aged ≥15 years with community-acquired APN who were admitted to one of the eight Korean hospitals included in this study between September 2017 and August 2018. Phylogenetic typing, multilocus sequence typing, and molecular characterization of β-lactamase resistance and plasmid-mediated quinolone resistance (PMQR) determinants were performed. The data were compared with those from a previous study with the same design conducted in 2010–2011. A total of 300 and 346 isolates were identified in 2010–2011 and 2017–2018, respectively. Among them, 76 (22.0%) and 77 (25.7%) FQ-R isolates were identified in 2010–2011 and 2017–2018, respectively. A significantly higher antimicrobial resistance against third-to fourth-generation cephalosporins, including cefotaxime (23.9% vs. 77.9%, P 
ISSN:1684-1182
1995-9133
DOI:10.1016/j.jmii.2022.01.001